Jonathan Rosenberg reflected on the CALGB 90601 trial—a negative study in advanced bladder cancer that, despite its challenges and lack of survival benefit, yielded valuable biospecimens and spurred ...

AstraZeneca receives FDA approval for Koselugo to treat adults with NF1 and inoperable plexiform neurofibromas, backed by ...

Jack Schlossberg’s decision to launch a bid for Congress in New York City last week was just the latest example of a Kennedy ...

Explore the geogenic causes, affected regions (West Bengal, Bihar, UP), and long-term health effects of arsenic in Indian ...